Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

senna

senna
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Senokot SYRUP, ORAL leaf extract 176 mg/5 mL      
Senokot TABLET, ORAL 8.6 mg      


Comments:

Senna leaf extract 176 mg (8.8 mg sennosides)/5 mL

Usual dose for both listed strengths (adults and children 12 and over) is 10-15 mL/day, not to exceed 15 mL BID.

 

 

Entire PEDIA-LAX line (senna, magnesium hydroxide, docusate, glycerin supp, and phosphate enema) is classified as non-formulary, not stocked. Interchange to the similar formulary product.

Reviewed: May 27, 2008 (PEDIA-LAX)

"Laxative of Choice” protocol


Last updated: Apr. 10, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.